Correlation Between Larimar Therapeutics and Nuvalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Nuvalent, you can compare the effects of market volatilities on Larimar Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Nuvalent.

Diversification Opportunities for Larimar Therapeutics and Nuvalent

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Larimar and Nuvalent is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Nuvalent go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Nuvalent

Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 1.81 times more return on investment than Nuvalent. However, Larimar Therapeutics is 1.81 times more volatile than Nuvalent. It trades about 0.07 of its potential returns per unit of risk. Nuvalent is currently generating about 0.07 per unit of risk. If you would invest  340.00  in Larimar Therapeutics on August 24, 2024 and sell it today you would earn a total of  273.00  from holding Larimar Therapeutics or generate 80.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Larimar Therapeutics  vs.  Nuvalent

 Performance 
       Timeline  
Larimar Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Nuvalent 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvalent are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Nuvalent disclosed solid returns over the last few months and may actually be approaching a breakup point.

Larimar Therapeutics and Nuvalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Larimar Therapeutics and Nuvalent

The main advantage of trading using opposite Larimar Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.
The idea behind Larimar Therapeutics and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.